Reducing Delay to Treatment of ST-Elevation Myocardial Infarction With Software Electrocardiographic Interpretation

Justin M Cloutier1, Christopher Hayes1, John Ducas1

  • 1Section of Cardiology, Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

CJC Open
|May 29, 2020
PubMed

Insights

Automated software diagnosis of ST-elevation myocardial infarction (STEMI) is accurate. Implementing this technology in emergency departments can significantly reduce door-to-device times for STEMI patients, improving outcomes.

Area of Science:

  • Cardiology
  • Medical Technology
  • Emergency Medicine

Background:

  • Prehospital diagnosis of ST-elevation myocardial infarction (STEMI) improves outcomes, but many patients still face delays upon arrival at the emergency department (ED).
  • Software-based electrocardiogram (ECG) diagnosis and electronic transmission to cardiologists show potential for reducing delays in STEMI treatment.
  • Emergency department (ED) presentation of STEMI can lead to delayed treatment and worse patient outcomes.

Purpose of the Study:

  • To assess the accuracy of a specific software (12SL) in diagnosing STEMI from ECGs.
  • To identify factors contributing to delays in door-to-device (D2D) times for STEMI patients in the ED.
  • To evaluate the potential reduction in D2D times if software diagnosis of STEMI triggered immediate cardiac catheterization laboratory activation.

Main Methods:

  • Retrospective analysis of STEMI patients from January 2015 to September 2016.
  • Extraction of D2D delay components, ED variables, and ECG data from a regional database.
  • Assessment of software 12SL accuracy for STEMI diagnosis and simulation of D2D time reduction with automated activation.

Main Results:

  • The software 12SL demonstrated high accuracy in diagnosing STEMI, with 90.5% sensitivity and 99.98% specificity.
  • An estimated 17-minute reduction in D2D time was possible for 90.5% of correctly identified STEMI patients, with a 4% false activation rate.
  • Female and older patients could experience even greater D2D time reductions (24 and 25 minutes, respectively).

Conclusions:

  • Patients with STEMI presenting to the ED experience significant system-related delays.
  • Automated software diagnosis of STEMI is accurate and can substantially decrease D2D times.
  • This technology offers a promising strategy to improve treatment efficiency and outcomes for STEMI patients.
Abstract

Related Concept Videos

Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
5.0K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
560
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
159
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
142
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
305